Skip to main content
  • English
  • Français
  • About Us
    • About Us
    • Our Purpose and Identity
    • Integrated Report 2021
    • Governance
      • Governance
      • Board of Directors
      • Executive Committee
    • Where we are
    • Through time
    • All Our Stories
      • All Our Stories
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
  • Your Health
    • Your Health
    • Health and Well-Being
    • Diabetes and Cardiovascular Diseases
    • Specialty Care
      • Specialty Care
      • Rare Diseases
      • Rare Blood Disorders
      • Neurology
      • Immunology
      • Oncology
        • Oncology
        • When Cancer Grows Old
          • When Cancer Grows Old
          • Contributions Initiative
          • Global collaboration
      • Patient Support
    • Vaccines
      • Vaccines
      • The Value of vaccines
      • How immunization works
      • Infectious Disease and Vaccines
        • Infectious Disease and Vaccines
        • COVID-19
        • Influenza
        • Meningococcal Meningitis
        • Pertussis
        • Poliomyelitis
        • Respiratory Syncytial Virus
        • Discover more
      • Research and Innovation
      • Vaccines Production
      • Vaccines Stories
    • Taking Medicines Safely
    • Patient Safety at Sanofi
  • Science & Innovation
    • Science & Innovation
    • Partnering
      • Partnering
      • Let's partner
      • Areas of Interest
        • Areas of Interest
        • China & Emerging Markets
        • Digital
        • General Medicines
        • Immunology
        • Neuroscience
        • Oncology
        • Out-Licensing
        • Rare Diseases
        • Technology Platforms
        • Vaccines
      • Meet the team
    • Research & Development
      • Research & Development
      • Sanofi Pipeline
      • Vaccines
      • Immunology and Inflammation
      • Neurology
      • Oncology
      • Pioneering Technology Platforms
        • Pioneering Technology Platforms
        • Genomic Medicine Technology Platform
        • mRNA Technology: Vaccines and Beyond
        • NANOBODY® Technology Platform
        • SYNTHORIN™ Technology Platform
      • Rare Blood Disorders R&D
      • Rare Diseases
      • Voices from the Lab
    • Clinical Trials & Results
      • Clinical Trials & Results
      • Phases
      • Our disclosure commitments
        • Our disclosure commitments
        • Sanofi Pharma
        • Sanofi Genzyme
        • Sanofi Pasteur
      • Our data sharing commitments
      • Managed Access Programs (MAPs)
      • Investigator Sponsored Studies and Externally Sponsored Collaboration
    • Collaboration & Awards
      • Collaboration & Awards
      • Europe
        • Europe
        • iAwards
        • iDEA-iTECH
      • North America
        • North America
        • iAwards
        • iDEA-iTECH
      • China
    • Science Stories
  • Our Responsibility
    • Our Responsibility
    • Access to Quality Healthcare – Sanofi Global Health
    • Environmental sustainability
    • Diversity, Equity and Inclusion
      • Diversity, Equity and Inclusion
      • Making an Impact
      • A Million Conversations
      • Global Poll
      • Board & Employee Groups
      • Gender Balance
        • Gender Balance
        • Women@Sanofi
      • Our Partners
      • Our LGBTQ+ Voice
    • Healthcare for all
      • Healthcare for all
      • Humanitarian Aid Programs
      • Contributing to the eradication, elimination and control of some infectious diseases
      • Fighting Against Falsified Medicine
      • Serving the needs of patients with non-communicable diseases
    • Corporate Citizenship
    • Foundation S (Endowment Fund)
    • Ethics & Transparency
      • Ethics & Transparency
      • Patient Safety at Sanofi
      • Our Code of Conduct
    • Suppliers
    • Document center
      • Document center
      • All factsheets
      • Access to Healthcare and Pricing
      • Country reports and other documents
      • CSR Strategy and Value Creation
      • Duty of Vigilance incl. Supply Chain
      • Environment
      • Ethics and Transparency
      • Governance, Controls and Procedures
      • Reporting Frameworks and Indicators
      • Social incl. Communities
  • |
  • Careers
    • Careers
    • Explore our career opportunities
    • A range of possibilities
      • A range of possibilities
      • Market access
      • Marketing
      • Medical
      • Production
      • Research & Development
      • Consumer Healthcare
      • Vaccines careers
      • Student / Graduate / Young Professionals
      • Discover more possibilities
    • Grow with us
      • Grow with us
      • Diversity & Inclusion
      • Development opportunity: how Sanofi empowers you
      • Benefits
  • Investors
    • Investors
    • Company overview
      • Company overview
      • Financial reporting center & Key data
      • Fixed income
    • Financial results and events
      • Financial results and events
      • Quarterly earnings at a glance
      • Investor presentations
      • Annual General Meetings
      • Broker conferences
    • Environmental, Social, Governance
      • Environmental, Social, Governance
      • Our Double Materiality Assessment
      • ESG Newsletters
    • Corporate governance
      • Corporate governance
      • Governance
      • Board of Directors
      • Executive Committee
      • Specialist committees
      • Compensations
      • Standards & rules
      • Regulated agreements
      • Internal Control
    • Sanofi share and ADRs
      • Sanofi share and ADRs
      • Share overview
        • Share overview
        • Shares & voting rights
      • Sanofi stock chart
      • Shareholding calculator
      • Dividends
      • ADRs
      • Shareholding structure
      • Vara consensus
      • Share repurchases
    • Reports and publications
      • Reports and publications
      • Financial and CSR reports
      • Shareholder publications
    • Individual Shareholders
      • Individual Shareholders
      • Welcome to Sanofi
      • Being a shareholder
        • Being a shareholder
        • Five reasons to be a Sanofi shareholder
        • How to buy Sanofi shares
        • Registered shares
      • Shareholder events
        • Shareholder events
        • Financial Calendar
        • Annual General Meetings
        • Participate in General Meetings
      • Reports and publications
        • Reports and publications
        • Financial and CSR reports
        • Shareholder publications
      • Shareholders committee
    • Regulated information
    • Contacts
  • Media
    • Media
    • Press releases
      • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
    • Articles
      • Articles
      • 2019
    • Contacts
    • Media Alert
  • |
  • Paris 2024 Partnership
Worldwide
EN
  • EN
  • FR

REGULATED INFORMATION IN FRANCE

Fees received by statutory auditors & Reports on corporate governance and internal control

  • Home
  • Investors
  • Regulated information
  • Fees received by auditors & Report on corporate governance

Fees received by statutory auditors

2021

  • Annual Report - Fees received by statutory auditors

2020

  • Annual Report - Fees received by statutory auditors

2019

  • Annual Report - Fees received by statutory auditors

2018

  • Annual Report - Fees received by statutory auditors

2017

  • Annual Report - Fees received by statutory auditors

2016

  • Annual Report - Fees received by statutory auditors

2015

  • Annual Report - Fees received by statutory auditors

2014

  • Annual Report - Fees received by statutory auditors

2013

  • Annual Report - Fees received by statutory auditors

2012

  • Annual Report - Fees received by statutory auditors

French financial-security-law reports of the Chairman of the Board on corporate governance and internal control

2019

  • Annual report on form 20-F 2019: Report of the Chairman of the Board of Directors

2018

  • Annual report on form 20-F 2018: Report of the Chairman of the Board of Directors

2017

  • Annual report on form 20-F 2017: Report of the Chairman of the Board of Directors

2016

  • Exhibit 99.1 to the annual report on form 20-F 2016: Report of the Chairman of the Board of Directors

2015

  • Exhibit 99.1 to the annual report on form 20-F 2015: Report of the Chairman of the Board of Directors

2014

  • Exhibit 99.1 to the annual report on form 20-F 2014: Report of the Chairman of the Board of Directors

2013

  • Exhibit 99.1 to the annual report on form 20-F 2013: Report of the Chairman of the Board of Directors

2012

  • Exhibit 99.1 to the annual report on form 20-F 2012: Report of the Chairman of the Board of Directors
Sanofi

    Follow us

  • Contact
  • Legal notice
  • Privacy & Data Protection
  • Cookies policy
  • Corporate code of ethics
  • Our publications
  • Sitemap
  • Our websites
  • Accessibility: partial compliance

© Sanofi 2004-2022 - All rights reserved

You are about to leave sanofi.com

If you wish to continue to this external website, click Proceed.

It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.

PROCEED